Compass Therapeutics, Inc.
CMPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $483,987 | $359,533 | $262,648 | $198,110 |
| - Cash | $46,212 | $22,856 | $41,048 | $43,483 |
| + Debt | $0 | $9,904 | $6,381 | $6,634 |
| Enterprise Value | $437,775 | $346,581 | $227,981 | $161,261 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14,240 | -$20,699 | -$17,602 | -$16,215 |
| % Margin | – | – | – | – |
| Net Income | -$14,259 | -$19,881 | -$16,633 | -$15,033 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.14 | -0.12 | -0.11 |
| % Growth | 28.6% | -16.7% | -9.1% | – |
| Operating Cash Flow | $0 | -$11,832 | -$13,208 | -$9,162 |
| Capital Expenditures | $7 | $0 | -$18 | $0 |
| Free Cash Flow | $0 | -$11,832 | -$13,226 | -$9,162 |